Radamized controlled trial ofremifentanil and propofol for nasotrachealintubation condition without the use of muscle relaxants

Radamized controlled trial ofremifentanil and propofol for nasotrachealintubation condition without the use of muscle relaxants - Study of remifentanil and propofol for nasotrachealintubation without the use of muscle relaxants

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009385

Enrollment

Registered

2012-12-27

Start date

2012-11-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients of nasotracheal intubation for general anesthesia.

Interventions

Remifentanil 0.5microg/kg/min and Propofol0.5mg/kg is prescribed for the patient, and anesthesia induction is carried out by propofol 5.0mg/kg/h after that. An isotonic sodium chloride solution is pre

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who had exodontia, a jaw cyst extirpation, and orthognathic surgery planned under general anesthesia.

Exclusion criteria

Exclusion criteria: BMI score are 25 or more patients. They are three or more patients in Mallampati score. The amount of openings is a patient of less than 3.5 cm. A patient who has a cervical vertebrae disease. They are three or more patients in Cormack and Lehane score. A patient who has two or more cardiopathy by the heartbeat classification of NYHA.

Design outcomes

Primary

Measure	Time frame
It classifies according to three steps for difficulty of laryngoscopy, state of vocal cords during intubation and body movement when intubation and cuff infration.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026